Savara Inc (SVRA) stock
SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.48+0.02 (+0.34%)
Close on Nov 17, 2026Market cap $920.46MP/E –Yield –
Savara enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Savara's enterprise value was $882.02M on Nov 11, 2026, against $1.26B a year earlier. Over the last 5 years it ranged from -$5.23M to $1.26B, with a median of $379.09M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $882.02M | -27.0% |
| 2025 | Dec 31, 2025 | $1.21B | +264.5% |
| 2024 | Dec 31, 2024 | $331.60M | -32.9% |
| 2023 | Dec 29, 2023 | $494.13M | +619.3% |
| 2022 | Dec 30, 2022 | $68.70M | – |
| 2021 | Dec 31, 2021 | -$4.09M | – |
| 2020 | Dec 31, 2020 | -$32.07M | -140.9% |
| 2019 | Dec 31, 2019 | $78.33M | -49.1% |
| 2018 | Dec 31, 2018 | $153.81M | -50.2% |
| 2017 | Dec 29, 2017 | $308.65M | – |
| 2016 | Dec 30, 2016 | -$6.79M | – |
See a number that looks wrong?